Frontiers in Antibiotics

Frontiers Media S.A.

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Frontiers in Antibiotics is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Frontiers Media S.A.
ISSN
2813-2467
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,950 CHF
Articles in DOAJ
112
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2023-03-27
Indexing
DOAJ
APC
1,950 CHF
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

112

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

120

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

13

i10-index

22

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-12
Added to DOAJ
2023-03-27
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918557185706676
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
Show all subjects (50)
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Identification and Susceptibility Testing
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Bacteriophages and microbial interactions
  • Mycobacterium research and diagnosis
  • Bacteriophages and microbial interactions
  • Mycobacterium research and diagnosis
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • Urinary Tract Infections Management
  • Antimicrobial agents and applications
  • Urinary Tract Infections Management
  • Microbial Natural Products and Biosynthesis
  • Microbial Natural Products and Biosynthesis
  • Nosocomial Infections in ICU
  • Antimicrobial Peptides and Activities
  • Antimicrobial agents and applications
  • Salmonella and Campylobacter epidemiology
  • Antimicrobial Peptides and Activities
  • Salmonella and Campylobacter epidemiology
  • Global Maternal and Child Health
  • Global Maternal and Child Health
  • Bacterial biofilms and quorum sensing
  • Bacterial biofilms and quorum sensing
  • Nosocomial Infections in ICU
  • Essential Oils and Antimicrobial Activity
  • Probiotics and Fermented Foods
  • Zoonotic diseases and public health
  • Neonatal and Maternal Infections
  • Essential Oils and Antimicrobial Activity
  • Probiotics and Fermented Foods
  • Vibrio bacteria research studies
  • Fecal contamination and water quality
  • Neonatal and Maternal Infections
  • Zoonotic diseases and public health
  • Antifungal resistance and susceptibility
  • Gut microbiota and health
  • Aquaculture disease management and microbiota
  • Genomics and Phylogenetic Studies
  • Genomics and Phylogenetic Studies
  • Antifungal resistance and susceptibility

Keywords (DOAJ)

  • antibiotic development
  • antibiotic resistance
  • pharmacology
  • antibiotics in clinical settings

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: